HYPERTONIA ÉS NEPHROLOGIA - eLitMed.hu

100 FINTA ERVIN ÉS MUNKATÁRSAI HYPERTONIA ÉS NEPHROLOGIA
5. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, et al. Sympathetic activation and loss of reflex sympathetic control
in mild congestive heart failure. Circulation 1995; 92:3206-3211.
6. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac
mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998;
351:478–484.
7. Osterziel KJ, Hanlein D, Willenbrock R, Eichhorn C, Luft F, Dietz R. Baroreflex sensitivity and cardiovascular mortality in patients with mild to
moderate heart failure. Br Heart J 1995; 73:517–522.
8. Frattola A, Parati G, Gamba P, Paleari F, Mauri G, Di Rienzo M, et al. Time and frequency domain estimates of spontaneous baroreflex
sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia 1997; 40:1470-1475.
9. Ziegler D, Laude D, Akila F, Elghozi JL. Time- and frequency-domain estimation of early diabetic cardiovascular autonomic neuropathy. Clin
Auton Res 2001; 11:369–376.
10. Billman GE, Schwartz PJ, Stone HL. The effects of daily exercise on susceptibility to sudden cardiac death. Circulation 1984; 69:1182-1189.
11. Parati G, Mutti E, Di Rienzo M, Castiglioni P, Mancia G. Beta-adrenergic blocking treatment and 24-hour baroreflex sensitivity in essential
hypertensive patients. Hypertension 1994; 23 (part 2):992-996.
12. Singh JP, Larson MG, Tsuji H, Evans JC, O’Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into
pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998; 32:293–297.
13. Greenwood JP, Stocker JB, Mary D. Single-unit sympathetic dischargequantitative assessment in human hypertensive disease. Circulation
1999; 100:1305–1310.
14. Malliani A, Pagani M, Lombardi F, Furlan R, Guzzetti S, Cerutti S. Spectral analysis to assess increased sympathetic tone in arterial
hypertension. Hypertension 1991; 17:III-36–III-42.
15. Guzzetti S, Piccaluga E, Casati R, Cerutti S, Lombardi F, Pagani M, et al. Sympathetic predominance in essential hypertension: a study
employing spectral analysis of heart rate variability. J Hypertens 1988; 6:711–717.
16. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task force of the European Society of Cardiology
and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17, 354-381.
17. Parati G, Di Rienzo M, Groppelli A, Pedotti A, Mancia G. Heart rate and blood pressure variability and their interaction in hypertension. In: Malik
M, Camm AJ (editors): Heart rate variability. Armonk, NY: Futura Publishing Company; 1995, pp. 467–478.
18. Bristow JD, Honour AJ, Pickering GW, Sleight P, Smyth HS. Diminished baroreflex sensitivity in high blood pressure. Circulation 1969;
39:48–54.
19. Mancia G, Mark AL. Arterial baroreflex in humans. In: Sheperd JT, Abboud FM (editors): The cardiovascular system. Baltimore: Williams and
Wilkins Co.; 1983, pp. 756–793.
20. Pagani M, Somers VK, Furlan R, Dell’Orto S, Conway J, Baselli G, et al. Changes in autonomic regulation induced by physical training in mild
hypertension. Hypertension 1988; 12:600–610.
21. Lucini D, Pagani M, Mela GS, Malliani A. Sympathetic restraint of baroreflex control of heart period in normotensive and hypertensive subjects.
Clin Sci 1994; 86:547–556.
22. Szabo B. Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol Ther. 2002 Jan; 93(1):1-35.
23. Alföldi S, Finta E. Folyamatos (beat to beat) ambuláns vérnyomás-monitorozás hypertoniában: az elsõ ambuláns ujjpletysmographiás vérnyomásmonitor,
a Portapres. In: Farsang Cs. (szerk.): A hypertonia kézikönyve (II. kiadás) 205-210. (Medintel, Budapest, 2002.)
24. Penáz J. Photoelectric measurement of blood pressure, volume and flow in the finger. In: Digest of the 10th Int. Conf. Med. Biol. Engineering,
Dresden, 1973:104.
25. Wesseling KH, De Wit B, Settles JJ, Klaver WH. On the indirect registration of finger blood pressure after Penaz. Funktbiol Med. 1982; 1:
245–250.
26. Farsang Cs, Lengyel M, Borbás S, et al on behalf of the VERITAS investigators: Value of rilmenidine therapy and its combination with perindopril
on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS) Curr Med Res Opin, 2003; 19:205-217.
27. de Châtel R. Rilmenidin (Tenaxum) hatása chronicus veseelégtelenségben szenvedõ, hypertoniás betegekben. Hazai multicentrikus vizsgálat
eredményei. Hypertonia és Nephrologia 2001; 5 (3): 150-156.
28. Jermendy A rilmenidin (Tenaxum) hatékonyságának és biztonságosságának vizsgálata enyhe és középsúlyos hypertoniával szövõdött, 2-es típusú
diabetes mellitusban. Diabetologia Hungarica 2000; 8: 241-248.
29. Kékes E: A rilmenidin (Tenaxum) additív antihypertensiv hatása kombinált kezelés során. Háziorvosi Továbbképzõ Szemle 2002;7, 434-437.
30. Girard A, Fevrier B, Elghozi JL, Cardiovascular variability after rilmenidine challenge: assessment of acute dosing effects by means of spectral
analysis. Fundam Clin Pharmacol 1995; 9:366-371.
31. Rónaszéki A. Monoterápiás rilmenidin (Tenaxum ® ) antihypertensiv hatása a sympathicus tónusra gyakorolt befolyás tükrében mérsékelt
hypertoniás betegeknél. Hazai multicentrikus vizsgálat. Hypertonia és Nephrologia 2003; 7 (3-4): 184-188.